What the company does
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company's lead drug candidate is the BIO101 to treat obesity, respiratory infections due to Covid-19, sarcopenia, and Duchenne Muscular Dystrophy (DMD). It has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. It also has an alliance with LynxKite Technologies Pte Ltd for the development of AI-driven drug discovery for longevity therapies. The company was incorporated in 2006 and is headquartered …
What the weekly tape is saying
ALBPS closed the latest completed week at 0.02 EUR. The 4-week return is -26.4% and the 12-week return is -40.0%. Trend Signal is inactive, Market Dynamics is 0.66. Setup signature: Risk-first tape with a 17/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.04 EUR
- Vs Trend Line
- -65.3%
- Fair Value
- 1.20 EUR
- Vs Fair Value
- -98.7%
- 52W High
- 0.22 EUR
- 52W Low
- 0.02 EUR
- Drawdown
- -93.0%
- Range Position
- 0.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- FR Healthcare
- Sector Rank
- 75 of 76
- Sector Percentile
- 1.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 69 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 27 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.66
- 4W MD Change
- 88.4%
- Relative Strength
- -83.46
- 4W RS Change
- -6.1%
- Expectation
- Negative
- Probability
- 28.36%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 16.2M
- 13W Average
- 22.2M
- 52W Average
- 8.0M
- Vs 13W
- 0.7x
- Vs 52W
- 2.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.8%
- 52W Volatility
- 9.9%
- Upside Weeks
- 14
- Downside Weeks
- 35
- Downside Breadth
- 67.3%
- Avg Gain / Loss
- 7.2% / -8.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 1.9M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.02 EUR | -19.0% | 0.04 EUR | 1.20 EUR | 0.66 | -83.46 | 16.2M | Off |
| 5 Jun 2026 | 0.02 EUR | -5.5% | 0.05 EUR | 1.25 EUR | 0.61 | -79.78 | 10.6M | Off |
| 29 May 2026 | 0.02 EUR | 5.8% | 0.05 EUR | 1.31 EUR | 0.47 | -79.04 | 8.9M | Off |
| 22 May 2026 | 0.02 EUR | -9.1% | 0.05 EUR | 1.36 EUR | 0.41 | -80.50 | 13.8M | Off |
| 15 May 2026 | 0.02 EUR | -1.0% | 0.06 EUR | 1.42 EUR | 0.35 | -78.68 | 44.4M | Off |
| 8 May 2026 | 0.02 EUR | 0.5% | 0.06 EUR | 1.48 EUR | -0.06 | -79.42 | 28.6M | Off |
| 1 May 2026 | 0.02 EUR | -4.1% | 0.06 EUR | 1.53 EUR | -0.36 | -80.04 | 63.3M | Off |
| 24 Apr 2026 | 0.02 EUR | 28.2% | 0.07 EUR | 1.61 EUR | -0.67 | -79.83 | 41.0M | Off |
| 17 Apr 2026 | 0.02 EUR | 1.2% | 0.07 EUR | 1.69 EUR | -0.88 | -85.20 | 12.7M | Off |
| 10 Apr 2026 | 0.02 EUR | -1.8% | 0.08 EUR | 1.77 EUR | -0.77 | -85.54 | 9.3M | Off |
| 3 Apr 2026 | 0.02 EUR | -18.2% | 0.08 EUR | 1.87 EUR | -0.51 | -85.21 | 13.1M | Off |
| 27 Mar 2026 | 0.02 EUR | -18.0% | 0.09 EUR | 1.98 EUR | -0.29 | -81.93 | 11.0M | Off |
| 20 Mar 2026 | 0.03 EUR | -21.1% | 0.09 EUR | 2.10 EUR | -0.07 | -78.52 | 15.7M | Off |
| 13 Mar 2026 | 0.03 EUR | -26.6% | 0.10 EUR | 2.21 EUR | 0.10 | -74.71 | 44.4M | Off |